VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine Researcher Honored by National Kidney Foundation

New York, NY—April 10, 2017—Paul Palevsky, MD has been selected to receive the Dr. J. Michael Lazarus Distinguished Award from the National Kidney Foundation (NKF) at its 26th annual Spring Clinical Meetings to be held in Orlando, Florida.  Dr. Palevsky is Professor of Medicine and Clinical and Translational Science in the Renal-Electrolyte Division at the University of Pittsburgh School of Medicine; and serves as Chief of the Renal Section at the VA Pittsburgh Healthcare System.
 
“Through his tremendous work, Dr. Palevsky has helped reduce the risk of acute kidney injury and increase the likelihood of recovery from it, for many thousands of patients,” said Michael Choi, MD, President and Chair, NKF Scientific Advisory Board. “He has also served on NKF’s Scientific Advisory Board and helped create professional education programs to improve detection and treatment of acute kidney injury.”
 
Dr. Palevsky will be presenting the Lazarus lecture on “We Don’t Have to Fail at Acute Renal Failure: A Multidisciplinary Approach to Quality Improvement” on Friday, April 21st at 8:45 a.m. at the Spring Clinical Meetings.
 
Dr. Palevsky’s research has primarily focused on acute kidney injury and critical care nephrology. He was the study chair of the VA/NIH Acute Renal Failure Trial Network (ATN) study evaluating intensity of renal replacement therapy in critically ill patients with acute kidney injury and currently serves as co-chair of the PRESERVE trial, evaluating the comparative effectiveness of saline and bicarbonate and the efficacy of N-acetylcysteine in preventing kidney damage following angiography.  
 
Among other clinical trials, Dr. Palevsky was a member of the planning and executive committee of the VA NEPHRON-D study, which compared monotherapy with an angiotensin receptor blocker to combination therapy with both an angiotensin blocker and an angiotensin converting enzyme inhibitor in slowing progression of diabetic kidney disease, and is a member of the steering committee for the EUPHRATES trial, which is evaluating extracorporeal endotoxin adsorption in severe sepsis.   Dr. Palevsky has published more than 200 original articles, reviews and book chapters, and has served as an editor to clinical journals focused on nephrology. 
 
“I am honored to receive this award from the National Kidney Foundation,” said Dr. Palevsky.  “Dr. Lazarus was a pioneer in dialysis and was a leader in applying quality improvement tools to improve the care of patients with kidney disease.  It is therefore appropriate that my talk will focus on opportunities for quality improvement in the care of patients with acute kidney injury.” 
 
The Dr. J. Michael Lazarus Distinguished Award was established to honor Dr. Lazarus for his major contributions to the clinical science and care of dialysis patients, and to recognize individuals whose research has yielded novel insights related to renal replacement therapy.  The award will be presented during the National Kidney Foundation 2017 Spring Clinical Meetings in Orlando, FL from April 18-22. 
 
For the past 26 years, nephrology healthcare professionals from across the country have come to the NKF Spring Clinical Meetings to learn about the newest developments related to all aspects of nephrology practice, network with colleagues, and present their research findings. The NKF Spring Clinical Meetings are designed for meaningful change in the multidisciplinary healthcare teams’ skills, performance, and patient health outcomes.  It is the only conference of its kind that focuses on translating science into practice for the entire healthcare team.  
 
Kidney Disease Facts
1 in 3 American adults is at risk for kidney disease.  26 million American adults have kidney disease—and most aren’t aware of it.  Risk factors for kidney disease include diabetes, high blood pressure, family history, and age 60+.  People of African American; Hispanic; Native American; Asian; or Pacific Islander descent are at increased risk for developing the disease.  African Americans are 3 ½ times more likely, and Hispanics 1 ½ times more likely, to experience kidney failure.
 

The National Kidney Foundation (NKF) is the largest, most comprehensive and longstanding organization dedicated to the awareness, prevention and treatment of kidney diseaseFor more information about NKF visit www.kidney.org